Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50034642
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365553(CHEMBL1957675)
Affinity DataIC50: 8.20nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365559(CHEMBL1957662)
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365553(CHEMBL1957675)
Affinity DataIC50: 32nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365555(CHEMBL1957649)
Affinity DataIC50: 54nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365538(CHEMBL1957656)
Affinity DataIC50: 63nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365549(CHEMBL1957670)
Affinity DataIC50: 90nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365547(CHEMBL1957668)
Affinity DataIC50: 110nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365551(CHEMBL1957673)
Affinity DataIC50: 130nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365546(CHEMBL1957667)
Affinity DataIC50: 130nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365558(CHEMBL1957661)
Affinity DataIC50: 130nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365537(CHEMBL1957655)
Affinity DataIC50: 150nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365555(CHEMBL1957649)
Affinity DataIC50: 170nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365545(CHEMBL1955884)
Affinity DataIC50: 170nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365556(CHEMBL1957659)
Affinity DataIC50: 190nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365532(CHEMBL1957623)
Affinity DataIC50: 270nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365549(CHEMBL1957670)
Affinity DataIC50: 280nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365531(CHEMBL1957650)
Affinity DataIC50: 340nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365538(CHEMBL1957656)
Affinity DataIC50: 350nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365533(CHEMBL1957651)
Affinity DataIC50: 370nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365543(CHEMBL1957665)
Affinity DataIC50: 380nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365532(CHEMBL1957623)
Affinity DataIC50: 390nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365539(CHEMBL1957657)
Affinity DataIC50: 420nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365544(CHEMBL1957666)
Affinity DataIC50: 510nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365557(CHEMBL1957660)
Affinity DataIC50: 530nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365540(CHEMBL1957658)
Affinity DataIC50: 600nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365533(CHEMBL1957651)
Affinity DataIC50: 680nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365537(CHEMBL1957655)
Affinity DataIC50: 680nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365547(CHEMBL1957668)
Affinity DataIC50: 730nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365546(CHEMBL1957667)
Affinity DataIC50: 750nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365531(CHEMBL1957650)
Affinity DataIC50: 760nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365534(CHEMBL1957652)
Affinity DataIC50: 790nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365536(CHEMBL1957654)
Affinity DataIC50: 810nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365545(CHEMBL1955884)
Affinity DataIC50: 830nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365541(CHEMBL1957663)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365542(CHEMBL1957664)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365543(CHEMBL1957665)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365536(CHEMBL1957654)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365554(CHEMBL1957648)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365548(CHEMBL1957669)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365551(CHEMBL1957673)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365540(CHEMBL1957658)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365539(CHEMBL1957657)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365541(CHEMBL1957663)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365544(CHEMBL1957666)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365552(CHEMBL1957674)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365548(CHEMBL1957669)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365535(CHEMBL1957653)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365550(CHEMBL1957672)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365535(CHEMBL1957653)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetTGF-beta receptor type-1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50365554(CHEMBL1957648)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: